In the complex and costly world of pharmaceutical development, the process of drug discovery remains one of the most significant bottlenecks, with scientists often describing compound optimization as ...
Variational AI, a Vancouver-based Healthcare Tech Company, advances Generative AI Drug Discovery by designing novel small ...
- CANDID-CNS TM achieves an 83% success rate for predicting small molecule brain penetration and distribution versus a 64% success rate for the industry standard CNS-MPO score - Only ~2% of small ...
This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...
Discover how Optibrium is transforming early-stage drug discovery through AI-powered software, generative chemistry, and 3D modelling. In this interview, Matt Segall, CEO at Optibrium, shares insights ...
Our goal with CosmeticAI™ was to make cosmetic ingredient development predictable rather than exploratory” — Dr. Lurong Pan, CEO of Ainnocence SAN FRANSICO, CA, UNITED STATES, January 1, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback